News: Incyte Corp (INCY.OQ)

INCY.OQ on NASDAQ Stock Exchange Global Select Market

25.83USD
4:00pm EDT
Price Change (% chg)

$2.42 (+10.34%)
Prev Close
$23.41
Open
$23.59
Day's High
$26.21
Day's Low
$23.59
Volume
566,142
Avg. Vol
312,570
52-wk High
$26.21
52-wk Low
$15.43

Search Stocks
Select another date:

Thu, Jun 13 2013

Lilly says arthritis pill effective in mid-stage study

- Eli Lilly and Co and Incyte Corp said their experimental drug was effective in reducing painful symptoms associated with rheumatoid arthritis after 52 weeks of treatment.

Lilly says arthritis pill effective in mid-stage study

June 13 - Eli Lilly and Co and Incyte Corp said their experimental drug was effective in reducing painful symptoms associated with rheumatoid arthritis after 52 weeks of treatment.

Incyte shares fall on fears over Jakafi-related infection

March 18 - Incyte Corp said a 75-year-old male patient taking its lead drug to treat a rare bone marrow disease developed a brain infection but that it was not immediately clear whether the drug, ruxolitinib, caused it.

Select another date:
Search Stocks